Cover Image
市場調查報告書

全球醫療技術市場未來趨勢

Global Medical Technologies Market 2014-2018

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 310040
出版日期 內容資訊 英文 122 Pages
訂單完成後即時交付
價格
Back to Top
全球醫療技術市場未來趨勢 Global Medical Technologies Market 2014-2018
出版日期: 2014年08月06日 內容資訊: 英文 122 Pages
簡介

所謂醫療技術,是為了保障健康狀態所使用的軟體解決方案、醫療設備、影像設備、診斷設備的集合體。在醫療技術市場,有醫院用硬體設備、麻醉與呼吸技術、體外診斷技術、牙科技術、醫療用電子機械技術、殘障人士之技術性支援、再利用型設備、可動式/非可動式植入設備技術、眼科與光學技術、拋棄式技術、實驗用設備、補充治療設備、診斷與治療用放射線技術、醫療機關用產品(與調整)、生物來源設備等。全球的醫療技術市場年複合成長率(CAGR),推算2014∼2018年達到4.38%。

本報告提供全球的各種醫療技術的市場相關分析、市場概要、結構和市場趨勢(今後5年的預測值)、各技術項目及各診療領域的詳細趨勢、各地區市場趨勢、推動、阻礙市場要素與其影響力、主要企業簡介、今後的市場機會等調查資料、考察。

第1章 摘要整理

第2章 簡稱集

第3章 分析範圍

  • 市場概要

第4章 市場分析技術

  • 市場分析的流程
  • 分析方法

第5章 簡介

第6章 市場環境

  • 市場概況
  • 市場規模與其預測
  • 波特的五力分析

第7章 各應用領域的市場分析

第8章 全球體外診斷(IVD)市場

  • 市場概況
  • 市場規模與其預測
  • 各地區的詳細趨勢

第9章 全球心臟病市場

第10章 全球影像診斷市場

第11章 全球整形外科市場

第12章 全球眼科市場

第13章 全球腎臟病市場

第14章 全球醫療IT市場

第15章 全球藥物遞輸市場

第16章 全球糖尿病治療市場

第17章 全球牙科市場

第18章 全球創傷護理市場

第19章 全球內視鏡市場

第20章 全球一般、整形外科市場

第21章 全球耳鼻喉科(ENT)市場

第22章 全球神經科市場

第23章 各地區的分析

第24章 購買標準

第25章 促進市場成長的要素

第26章 推動因素與其影響力

第27章 市場課題

第28章 推動因素、課題的影響力

第29章 市場趨勢

第30章 市場趨勢與其影響

第31章 供應商環境

  • 競爭方案
    • 近幾年的主要趨勢
    • 企業合併、收購(M&A)
  • 市場佔有率分析
    • Johnson & Johnson
    • Medtronic
    • Siemens
    • GE Healthcare
    • Roche
  • 其他的著名供應商

第32章 主要供應商分析

  • GE Healthcare
    • 主要資料
    • 產業概要
    • 產業結構(各部門、各地區)
    • 產業策略
    • 近幾年的主要趨勢
    • SWOT分析
  • Johnson and Johnson
  • Medtronic Inc.
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics Inc.

第33章 其他相關分析

圖表一覽

目錄
Product Code: IRTNTR3906

About Medical Technologies

Medical technology is a collective term for software solutions, medical devices, imaging and diagnostic equipment used to ensure good health. The Global Medical Technologies market covers active implantable technology, hospital hardware, anaesthetic and respiratory technology, In vitro diagnostics technology, dental technology, electromechanical medical technology, technical aids for disabled, reusable instruments, non-active implantable technology, ophthalmic and optical technology, single-use technology, laboratory equipment, complementary therapy devices, diagnostic and therapeutic radiation technology, healthcare facility products and adaptations and biological-derived devices.

TechNavio's analysts forecast the Global Medical Technologies market will grow at a CAGR of 4.38 percent over the period 2014-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Medical Technologies market for the period 2014-2018. To calculate the market size, the report considers revenue from the sales of preventive, diagnostic, treatment, alleviating, monitoring technologies; healthcare software and in vitro diagnostics used in diseased, injured or handicapped people. The report covers technologies for investigation, replacement or modification of anatomy and physiology such as Left Ventricular Assist Devices, robotic-assisted surgery, diagnostic imaging services, cervical disc replacements, Transcatheter Valve Replacements, intraocular lenses, renal denervation, mobile health and molecular diagnostics. The scope of this report excludes contract manufacturing organizations, contract research organizations and technologies which primarily act by exerting metabolic, immunological or pharmacological actions.

The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Medical Technologies market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

TechNavio's report, the Global Medical Technologies Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Medical Technologies market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • GE Healthcare
  • Johnson & Johnson
  • Medtronic Inc.
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics Inc.

Other Prominent Vendors

  • Alcon Inc.
  • Danaher Corp.
  • Edwards Lifesciences
  • Essilor International
  • Getinge Group
  • HOYA Corp.
  • NIDEK Co. Ltd.
  • Novartis AG
  • NuVasive Inc.
  • Koninklijke Philips N.V.
  • Sanofi SA
  • Shimadzu Corp.
  • Smith & Nephew
  • St. Jude Medical Inc.
  • Stryker Corp.
  • Sysmex Corp.
  • Terumo Corp.
  • The Cooper Companies Inc.
  • Thermo Fisher Scientific Inc.
  • TOPCON Corp.
  • Toshiba Corp.
  • Zimmer Holdings Inc.
  • Key Market Driver
  • Aging Population.
  • For a full, detailed list, view our report.

Key Market Challenge

  • Pricing Pressure.

For a full, detailed list, view our report.

Key Market Trend

  • Emergence of User-Friendly Technologies.

For a full, detailed list, view our report.

Key questions answered in this report:

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Application

08. Global IVD Market

  • 08.1. Market Overview
  • 08.2. Market Size and Forecast
  • 08.3. Geographical Segmentation

09. Global Cardiology Market

  • 09.1. Market Overview
  • 09.2. Market Size and Forecast

10. Global Diagnostic Imaging Market

  • 10.1. Market Overview
  • 10.2. Market Size and Forecast
  • 10.3. Geographical Segmentation

11. Global Orthopedics Market

  • 11.1. Market Overview
  • 11.2. Market Size and Forecast
  • 11.1. Geographical Segmentation

12. Global Ophthalmics Market

  • 12.1. Market Overview
  • 12.2. Market Size and Forecast

13. Global Nephrology Market

  • 13.1. Market Size and Forecast

14. Global Healthcare IT Market

  • 14.1. Market Size and Forecast

15. Global Drug Delivery Market

  • 15.1. Market Size and Forecast

16. Global Diabetic Care Market

  • 16.1. Market Size and Forecast

17. Global Dental Market

  • 17.1. Market Size and Forecast

18. Global Wound Management Market

  • 18.1. Market Size and Forecast

19. Global Endoscopy Market

  • 19.1. Market Size and Forecast

20. Global General and Plastic Surgery Market

  • 20.1. Market Size and Forecast

21. Global ENT Market

  • 21.1. Market Size and Forecast

22. Global Neurology Market

  • 22.1. Market Size and Forecast

23. Geographical Segmentation

24. Buying Criteria

25. Market Growth Drivers

26. Drivers and their Impact

27. Market Challenges

28. Impact of Drivers and Challenges

29. Market Trends

30. Trends and their Impact

31. Vendor Landscape

  • 31.1. Competitive Scenario
    • 31.1.1. Key News
    • 31.1.2. Mergers and Acquisitions
  • 31.2. Market Share Analysis 2013
    • 31.2.1. Johnson & Johnson
    • 31.2.2. Medtronic
    • 31.2.3. Siemens
    • 31.2.4. GE Healthcare
    • 31.2.5. Roche
  • 31.3. Other Prominent Vendors

32. Key Vendor Analysis

  • 32.1. GE Healthcare
    • 32.1.1. Key Facts
    • 32.1.2. Business Overview
    • 32.1.3. Business Segmentation
    • 32.1.4. Business Strategy
    • 32.1.5. Key Developments
    • 32.1.6. SWOT Analysis
    • 32.1.7. Strengths
    • 32.1.8. Weaknesses
    • 32.1.9. Opportunities
    • 32.1.10. Threats
  • 32.2. Johnson and Johnson
    • 32.2.1. Key Facts
    • 32.2.2. Business Overview
    • 32.2.3. Business Segmentation by Revenue 2013
    • 32.2.4. Business Segmentation by Revenue 2012 and 2013
    • 32.2.5. Geographical Segmentation by Revenue 2013
    • 32.2.6. Business Strategy
    • 32.2.7. Key Information
    • 32.2.8. SWOT Analysis
    • 32.2.9. Strengths
    • 32.2.10. Weaknesses
    • 32.2.11. Opportunities
    • 32.2.12. Threats
  • 32.3. Medtronic Inc.
    • 32.3.1. Key Facts
    • 32.3.2. Business Overview
    • 32.3.3. Business Segmentation
    • 32.3.4. Revenue by Business Segmentation
    • 32.3.5. Revenue Comparison 2012 and 2013
    • 32.3.6. Revenue Segmentation by Geography
    • 32.3.7. Business Strategy
    • 32.3.8. Key Developments
    • 32.3.9. SWOT Analysis
    • 32.3.10. Strengths
    • 32.3.11. Weaknesses
    • 32.3.12. Opportunities
    • 32.3.13. Threats
  • 32.4. Roche Diagnostics
    • 32.4.1. Key Facts
    • 32.4.2. Business Overview
    • 32.4.3. Business Segmentation by Revenue 2013
    • 32.4.4. Geographical Segmentation by Revenue 2013
    • 32.4.5. Business Strategy
    • 32.4.6. Recent Developments
    • 32.4.7. SWOT Analysis
    • 32.4.8. Strengths
    • 32.4.9. Weaknesses
    • 32.4.10. Opportunities
    • 32.4.11. Threats
  • 32.5. Siemens Healthcare Diagnostics Inc.
    • 32.5.1. Key Facts
    • 32.5.2. Business Overview
    • 32.5.3. Recent Developments
    • 32.5.4. Business Strategy
    • 32.5.5. SWOT Analysis
    • 32.5.6. Strengths
    • 32.5.7. Weaknesses
    • 32.5.8. Opportunities
    • 32.5.9. Threats

33. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Medical Technology Market 2013-2018 (US$ million)
  • Exhibit 3: Global Medical Technologies Market Segmentation by Application
  • Exhibit 4: Global Medical Technologies Market Segmentation 2013
  • Exhibit 5: Global Medical Technologies Market Segmentation 2018
  • Exhibit 6: Global IVD Market Segmentation by Application
  • Exhibit 7: Global IVD Market Segmentation by Application 2013
  • Exhibit 8: Global IVD Market 2013-2018 (US$ million)
  • Exhibit 9: Global IVD Market by Geographical Segmentation 2013
  • Exhibit 10: Global Cardiology Market Segmentation by Product Type
  • Exhibit 11: Global Cardiology Market 2013-2018 (US$ million)
  • Exhibit 12: Global Diagnostic Imaging Market Segmentation by Product Type
  • Exhibit 13: Global Diagnostic Imaging Market Segmentation by Product Type 2013
  • Exhibit 14: Segmentation of X-ray Systems
  • Exhibit 15: Segmentation of CT Scanners
  • Exhibit 16: Segmentation of Ultrasound Systems
  • Exhibit 17: Segmentation of MRI Systems
  • Exhibit 18: Market Segmentation of Nuclear Imaging Systems
  • Exhibit 19: Global Diagnostic Imaging Market 2013-2018 (US$ million)
  • Exhibit 20: Global Diagnostic Imaging Market by Geographical Segmentation 2013
  • Exhibit 21: Global Orthopedics Market Segmentation by Application
  • Exhibit 22: Global Orthopedics Market Segmentation by Anatomy
  • Exhibit 23: Global Orthopedics Market 2013-2018 (US$ million)
  • Exhibit 24: Global Ophthalmic Market Segmentation by Application
  • Exhibit 25: Global Ophthalmic Market 2013-2018 (US$ million)
  • Exhibit 26: Global Nephrology Market 2013-2018 (US$ million)
  • Exhibit 27: Global Healthcare IT Market 2013-2018 (US$ million)
  • Exhibit 28: Global Drug Delivery Market 2013-2018 (US$ million)
  • Exhibit 29: Global Diabetic Care Market 2013-2018 (US$ million)
  • Exhibit 30: Global Dental Market 2013-2018 (US$ million)
  • Exhibit 31: Global Wound Management Market 2013-2018 (US$ million)
  • Exhibit 32: Global Endoscopy Market 2013-2018 (US$ million)
  • Exhibit 33: Global General and Plastic Surgery Market 2013-2018 (US$ million)
  • Exhibit 34: Global ENT Market 2013-2018 (US$ million)
  • Exhibit 35: Global Neurology Market 2013-2018 (US$ million)
  • Exhibit 36: Global 60+ Population and 60 and older total population (in billion)
  • Exhibit 37: Percentage Share of Johnson & Johnson's Medical Devices and Diagnostics in Total Sales
  • Exhibit 38: Geography-wise Segmentation of Johnson & Johnson's Medical Devices and Diagnostics Segment
  • Exhibit 39: Johnson & Johnson's Medical Devices and Diagnostics Segmentation by Application
  • Exhibit 40: Percentage Share of Johnson & Johnson's Medical Devices and Diagnostics Segments in 2013 (in US$ million)
  • Exhibit 41: Revenue of Johnson & Johnson's Medical Devices and Diagnostics Segments in 2013 (in US$ million)
  • Exhibit 42: Geography-wise Segmentation of Medtronic
  • Exhibit 43: Medtronic's Product Portfolio Segmentation by Application
  • Exhibit 44: Percentage Share of Medtronic's Segments in FY2014 (in US$ million)
  • Exhibit 45: Segmentation of Medtronic's Cardiac and Vascular Group
  • Exhibit 46: Percentage Share of Medtronic's Cardiac and Vascular Group Sub-segments in FY2014 (in US$ million)
  • Exhibit 47: Segmentation of Medtronic's Restorative Therapies Group
  • Exhibit 48: Percentage Share of Medtronic's Restorative Therapies Group Sub-segments in FY2014 (in US$ million)
  • Exhibit 49: Revenue of Medtronics segments in FY2014 (in US$ million)
  • Exhibit 50: Percentage Share of Roche's Diagnostics in Total Sales
  • Exhibit 51: Geography-wise Segmentation of Roche Diagnostics
  • Exhibit 52: Roche Diagnostic's Product Portfolio Segmentation by Application
  • Exhibit 53: Percentage Share of Roche Diagnostics Sub-segments in 2013 (in US$ million)
  • Exhibit 54: Revenue of Roche Diagnostics Sub-segments in 2013 (in US$ million)
  • Exhibit 55: GE Healthcare: Business Segmentation 2013
  • Exhibit 56: Johnson and Johnson: Business Segmentation by Revenue 2013
  • Exhibit 57: Johnson and Johnson: Business Segmentation by Revenue 2012 and 2013 (US$ billions)
  • Exhibit 58: Johnson and Johnson: Geographical Segmentation by Revenue 2013
  • Exhibit 1: Medtronic Inc.: Business Segmentation
  • Exhibit 2: Medtronic Inc.: Revenue by Business Segmentation 2013
  • Exhibit 3: Medtronic Inc.: Revenue Comparison 2012 and 2013 (US$ million)
  • Exhibit 4: Medtronic Inc.: Revenue Segmentation by Geography 2013
  • Exhibit 59: Roche Diagnostics: Business Segmentation by Revenue 2013
  • Exhibit 60: Roche Diagnostics: Geographical Segmentation by Revenue 2013
Back to Top